NeilJShahMD

PubMed

• Artificial Intelligence-Assisted Cancer Status Detection in Radiology Reports.
  Ankur Arya, Andrew Niederhausern, Nadia Bahadur, Chelsea Nichols, Avijit Chatterjee, John Philip, Neil J Shah> ;Cancer Research Communications. 2024 Apr 9
• A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer.
  Ritesh R Kotecha, Sahil D Doshi, Andrea Knezevic, Joshua Chaim, Yingbei Chen, Rachel Jacobi, Mark Zucker, Ed Reznik, Deaglan McHugh, Neil J Shah, Emily Feld, David H A...> ;European Urology Oncology. 2023 Nov 7
• Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.
  Kotecha, R., Knezevic, A., Arora, K., Bandlamudi, C., Kuo, F., Carlo, M., Fitzgerald, K., Feldman, D., Shah, N., Reznik, E., Hakimi, A., Carrot-Zhang, J., Mandelker, D...> ;Cancer. 2024 Mar 1
• 2 citations
  Real-world clinical outcomes of patients with metastatic renal cell carcinoma receiving pembrolizumab + axitinib vs. ipilimumab + nivolumab.
  Neil J Shah, Sneha D Sura, Reshma Shinde, Junxin Shi, Puneet Singhal, Rodolfo F Perini, Robert J Motzer> ;Urologic Oncology. 2023 Nov 1
• 7 citations
  Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in Pe...
  Dobbs, R. W., Talal El Zarif, Amin H Nassar, Elio Adib, Bailey G Fitzgerald, Jiaming Huang, Tarek H Mouhieddine, Paul G Rubinstein, Taylor Nonato, Rana R McKay, Mingji...> ;Journal of Clinical Oncology. 2023 Jul 20
• 9 citations
  Real-world Treatment Patterns and Clinical Outcomes for Metastatic Renal Cell Carcinoma in the Current Treatment Era.
  Neil J Shah, Sneha D Sura, Reshma Shinde, Junxin Shi, Puneet K Singhal, Nicholas J Robert, Nicholas J Vogelzang, Rodolfo F Perini, Robert J Motzer> ;European Urology Open Science. 2023 Mar 1
• 2 citations
  Dermatologic immune-related adverse events to checkpoint inhibitors in cancer.
  Neil J Shah, Mario E Lacouture> ;The Journal of Allergy and Clinical Immunology. 2023 Feb 1
• 5 citations
  Progression-free Survival After Second Line of Therapy for Metastatic Clear Cell Renal Cell Carcinoma in Patients Treated with First-line Immunotherapy Combinations.
  Kelly N Fitzgerald, Cihan Duzgol, Andrea Knezevic, Natalie Shapnik, Ritesh Kotecha, David H Aggen, Maria I Carlo, Neil J Shah, Martin H Voss, Darren R Feldman, Robert ...> ;European Urology. 2023 Mar 1
• Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint...
  Dongyu Zhang, Neil J Shah, Michael Cook, Matthew Blackburn, Michael T Serzan, Shailesh Advani, Arnold L Potosky, Subha Madhavan, Anas Belouali, Michael B Atkins, Dejan...> ;Cancers. 2022 Sep 19
• 51 citations
  Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates.
  Chung-Han Lee, Martin H Voss, Maria Isabel Carlo, Ying-Bei Chen, Mark Zucker, Andrea Knezevic, Robert A Lefkowitz, Natalie Shapnik, Chloe Dadoun, Ed Reznik, Neil J Sha...> ;Journal of Clinical Oncology. 2022 Jul 20
• 3 citations
  Matched Molecular Profiling of Cell-Free DNA and Tumor Tissue in Patients With Advanced Clear Cell Renal Cell Carcinoma.
  Ritesh R Kotecha, Erika Gedvilaite, Ryan Ptashkin, Andrea Knezevic, Samuel Murray, Ian Johnson, Natalie Shapnik, Darren R Feldman, Maria I Carlo, Neil J Shah, Marisa D...> ;JCO Precision Oncology. 2022 Jul 1
• 3 citations
  The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring Steroids.
  Neil J Shah, Michael R Cook, Tianmin Wu, Shaked Lev-Ari, Matthew J Blackburn, Michael T Serzan, Adil Alaoui, Jaeil Ahn, Michael B Atkins> ;Journal of the National Comprehensive Cancer Network. 2022 Jul 1
• 4 citations
  Contribution of the Skin-Gut Axis to Immune-Related Adverse Events with Multi-System Involvement.
  Alyce M Kuo, Lukas Kraehenbuehl, Stephanie King, Donald Y M Leung, Elena Goleva, Andrea P Moy, Mario E Lacouture, Neil J Shah, David M Faleck> ;Cancers. 2022 Jun 17
• 1 citations
  The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer.
  Shah, N., Patel, V., Zhong, X., Pina, L., Hawley, J., Lin, E., Gartrell, B., Febles, V., Wise, D., Qin, Q., Mellgard, G., Joshi, H., Nauseef, J., Green, D., Vlachoster...> ;JNCI Cancer Spectrum. 2022 May 2
• 8 citations
  Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer...
  Dongyu Zhang, Neil J Shah, Michael Cook, Matthew Blackburn, Michael T Serzan, Shailesh Advani, Arnold L Potosky, Michael B Atkins, Dejana Braithwaite> ;Cancers. 2021 Dec 3
• 26 citations
  Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;JAMA Network Open. 2021 Nov 1
• 15 citations
  Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.
  Hong Truong, Rania Sheikh, Ritesh Kotecha, Yelena Kemel, Peter Reisz, Andrew T. Lenis, Nikita Mehta, Aliya Khurram, Vijai Joseph, Diana Mandelker, Alicia Latham, Ozge ...> ;European Urology Oncology. 2021 Oct 12
• 6 citations
  PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine
  , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Journal for Immunotherapy of Cancer. 2021 Oct 1
• 8 citations
  PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma.
  Geoffrey T. Gibney, Jacob Zaemes, Shelly Shand, Neil J. Shah, David M Swoboda, Kellie Gardner, Arash Radfar, Vesna Petronic-Rosic, Michael J. Reilly, Waddah B. Al-Refa...> ;Journal for Immunotherapy of Cancer. 2021 Oct 1
• Immune tolerance with combined allogeneic haplo-identical haematopoietic stem cell transplant and renal transplant.
  Kimberley Doucette, Neil J. Shah, Michele Donato, David S. Siegel, Scott D. Rowley, David H. Vesole> ;British Journal of Haematology. 2021 Jun 16
• 5 citations
  Automated Identification of Patients With Immune-Related Adverse Events From Clinical Notes Using Word Embedding and Machine Learning.
  Samir Gupta, Anas Belouali, Neil J. Shah, Michael B. Atkins, Subha Madhavan> ;JCO Clinical Cancer Informatics. 2021 May 14
• 21 citations
  Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade.
  Jason Beattie, Hira Rizvi, Paige Fuentes, Jia Luo, Adam J. Schoenfeld, I-Hsin Lin, Michael A. Postow, Margaret K. Callahan, Martin H. Voss, Neil J. Shah, Allison Betof...> ;Journal for Immunotherapy of Cancer. 2021 Feb 1
• 51 citations
  Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors.
  Anita Gul, Tyler F. Stewart, Charlene Mantia, Neil J. Shah, Emily Stern Gatof, Ying Long, Kimberly D Allman, Moshe Chaim Ornstein, Hans J. Hammers, David F. McDermott,...> ;Journal of Clinical Oncology. 2020 Jun 3
• 79 citations
  Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection
  Neil J. Shah, Ghassan Al-Shbool, Matthew Blackburn, Michael R. Cook, Anas Belouali, Stephen V. Liu, Subha Madhavan, Aiwu Ruth He, Michael B. Atkins, Geoffrey T. Gibney...> ;Journal for Immunotherapy of Cancer. 2019 Dec 17
• 25 citations
  A case of checkpoint inhibitor-induced celiac disease.
  Dana Alsaadi, Neil J. Shah, Aline Charabaty, Michael B. Atkins> ;Journal for Immunotherapy of Cancer. 2019 Aug 5
• Join now to see all

Lectures

• Real-world outcomes of underrepresented patient populations treated with immune checkpoint inhibitors (ICIs): African American descent, poor ECOG performance status, a... 
  2019 ASCO Annual Meeting - 6/1/2019